CVC India bets under pressure as Aavas loses value

GreyOak summary

CVC Capital Partners faces pressure on two Indian investments: Aavas Financiers lost 33% of its value since acquisition due to regulatory scrutiny and leadership changes, while Cohizon Life Sciences saw a 40% revenue contraction. Despite Aavas reporting a 16.4% profit rise in FY27, the mark-to-market loss remains significant. Cohizon continues to struggle with a prolonged industry downturn.